Clinical trial

AryoTrust® (Trastuzumab) Safety Study

NCT06021379

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2017-02-22

PhaseN/A

Study timeline

Study start (actual)2017-02-22Date precision: day

Registry last updated2023-10-31

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Interventions

TrastuzumabDRUG · verified · RxNorm: trastuzumab

Sponsors & collaborators

AryoGen Pharmed Co.lead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06021379 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.